Overview

Safety Study of the VEGA UV-A System to Treat Ectasia

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL) when used to treat ectasia.
Phase:
Phase 3
Details
Lead Sponsor:
Topcon Medical Systems, Inc.
Treatments:
Riboflavin